SCHEMBL23703153

SCHEMBL23703153

CS(=O)(=O)NCc1cccc(-c2cn([C@H]3C[C@@H](CNCc4ccccc4)C3)c3ncnc(N)c23)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 14/20 0.61
▸ ABL1 P00519 6/20 0.60
▸ EGFR P00533 6/20 0.60
▸ ABL2 P42684 4/20 0.60
▸ INSR P06213 6/20 0.55
▸ SRC P12931 5/20 0.55
▸ LCK P06239 4/20 0.55
▸ KIT P10721 4/20 0.55
▸ KDR P35968 4/20 0.55
▸ LYN P07948 4/20 0.55
▸ RET P07949 4/20 0.55
▸ FGFR1 P11362 3/20 0.55
▸ FLT1 P17948 3/20 0.55
▸ FLT3 P36888 3/20 0.55
▸ PDGFRA P16234 3/20 0.55
▸ FGFR4 P22455 3/20 0.55
▸ CSF1R P07333 2/20 0.55
▸ MET P08581 2/20 0.55
▸ PDGFRB P09619 2/20 0.55
▸ FGFR2 P21802 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30049696 1.00 IGF1R (0.61) IGF1RABL1EGFRABL2INSR
SCHEMBL23703157 1.00 IGF1R (0.61) IGF1RABL1EGFRABL2INSR
SCHEMBL30050447 0.90 IGF1R (0.68) IGF1RABL1EGFRABL2INSR
SCHEMBL30051038 0.90 IGF1R (0.68) IGF1RABL1EGFRABL2INSR
SCHEMBL23703163 0.90 IGF1R (0.68) IGF1RABL1EGFRABL2INSR
SCHEMBL23703119 0.90 IGF1R (0.68) IGF1RABL1EGFRABL2INSR
SCHEMBL23703120 0.90 IGF1R (0.68) IGF1RABL1EGFRABL2INSR
SCHEMBL23703241 0.89 IGF1R (0.57) IGF1RABL1EGFRABL2INSR
SCHEMBL23703240 0.89 IGF1R (0.57) IGF1RABL1EGFRABL2INSR
SCHEMBL30050475 0.89 IGF1R (0.57) IGF1RABL1EGFRABL2INSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12195490-B2 STRAD-binding agents and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-14 — — US disclosed
EP-4097223-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-07 — — EP disclosed
WO-2021155004-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-05 — — WO disclosed
WO-2021155004-A1 STRAD-BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12195490-B2 STRAD-binding agents and uses thereof STRAP, STRA6, PLAUR IGF1R 1979/4885ABL1 2110/4885EGFR 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback